Massive transfusion in cardiac surgery: The impact of blood component ratios on clinical outcomes and survival

Anesthesia and Analgesia

Volumn 124, Issue 6, 2017, Pages 1777-1782

  Delaney, Meghan ^a   Stark, Paul C ^b   Suh, Minhyung ^b   Triulzi, Darrell J ^c   Hess, John R ^d   Steiner, Marie E ^e   Stowell, Christopher P ^f   Sloan, Steven R ^g,h  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g BOSTON CHILDREN S HOSPITAL   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CREATININE; HEMOGLOBIN;

ADULT; AGED; APHERESIS; ARTICLE; BLOOD COMPONENT; CLINICAL OUTCOME; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; FEMALE; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORGAN DYSFUNCTION SCORE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; STERNOTOMY; SURVIVAL; THROMBOCYTE; THROMBOCYTE TRANSFUSION; ADVERSE EFFECTS; BLOOD LOSS, SURGICAL; COMPARATIVE STUDY; HOSPITAL DISCHARGE; HOSPITAL MORTALITY; KAPLAN MEIER METHOD; LENGTH OF STAY; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BLOOD LOSS, SURGICAL; CARDIAC SURGICAL PROCEDURES; ERYTHROCYTE TRANSFUSION; FEMALE; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIER ESTIMATE; LENGTH OF STAY; LINEAR MODELS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; ORGAN DYSFUNCTION SCORES; PATIENT DISCHARGE; PLATELET TRANSFUSION; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 85015847593     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000001926     Document Type: Article

References (19)

1. Dzik WS, Ziman A, Cohen C, et al. Biomedical Excellence for Safer Transfusion Collaborative. Survival after ultramassive transfusion: a review of 1360 cases. Transfusion. 2016; 56: 558-563.
2. Jacobs JP, Shahian DM, Prager RL, et al. Introduction to the STS national database series: outcomes analysis, quality improvement, and patient safety. Ann Thorac Surg. 2015; 100: 1992-2000.
3. Koch CG, Li L, Duncan AI, et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med. 2006; 34: 1608-1616.
4. Stanworth SJ, Morris TP, Gaarder C, et al. Reappraising the concept of massive transfusion in trauma. Crit Care. 2010; 14: R239.
5. Zatta AJ, McQuilten ZK, Mitra B, et al. Massive Transfusion Registry Steering Committee. Elucidating the clinical characteristics of patients captured using different definitions of massive transfusion. Vox Sang. 2014; 107: 60-70.
6. Kehara H, Takano T, Ohashi N, Terasaki T, Amano J. Platelet function during cardiopulmonary bypass using multiple electrode aggregometry: comparison of centrifugal and roller pumps. Artif Organs. 2014; 38: 924-930.
7. Harker LA, Malpass TW, Branson HE, Hessel EA II, Slichter SJ. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release. Blood. 1980; 56: 824-834.
8. Perek B, Stefaniak S, Komosa A, Perek A, Katynska I, Jemielity M. Routine transfusion of platelet concentrates effectively reduces reoperation rate for bleeding and pericardial effusion after elective operations for ascending aortic aneurysm. Platelets. 2016: 1-7.
9. Holcomb JB, Tilley BC, Baraniuk S, et al. PROPPR Study Group. Transfusion of plasma, platelets, and red blood cells in a 1: 1: 1 vs a 1: 1: 2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015; 313: 471-482.
10. Sniecinski RM, Levy JH. Bleeding and management of coagulopathy. J Thorac Cardiovasc Surg. 2011; 142: 662-667.
11. Alghamdi AA, Davis A, Brister S, Corey P, Logan A. Development and validation of Transfusion Risk Understanding Scoring Tool (TRUST) to stratify cardiac surgery patients according to their blood transfusion needs. Transfusion. 2006; 46: 1120-1129.
12. Steiner ME, Ness PM, Assmann SF, et al. Effects of red-cell storage duration on patients undergoing cardiac surgery. N Engl J Med. 2015; 372: 1419-1429.
13. Holcomb JB, Jenkins D, Rhee P, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma. 2007; 62: 307-310.
14. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995; 23: 1638-1652.
15. Hébert PC, Yetisir E, Martin C, et al. Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases?. Crit Care Med. 2001; 29: 227-234.
16. Buckley TA, Gomersall CD, Ramsay SJ. Validation of the multiple organ dysfunction (MOD) score in critically ill medical and surgical patients. Intensive Care Med. 2003; 29: 2216-2222.
17. Steiner ME, Assmann SF, Levy JH, et al. Addressing the question of the effect of RBC storage on clinical outcomes: the Red Cell Storage Duration Study (RECESS) (Section 7). Transfus Apher Sci. 2010; 43: 107-116.
18. Cotton BA, Reddy N, Hatch QM, et al. Damage control resuscitation is associated with a reduction in resuscitation volumes and improvement in survival in 390 damage control laparotomy patients. Ann Surg. 2011; 254: 598-605.
19. Holcomb JB, del Junco DJ, Fox EE, et al. PROMMTT Study Group. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg. 2013; 148: 127-136.